Table 1.

Schedule of trial measurements for primary and secondary outcomes.

Study phase		Screen/enroll	Allocation	Intervention period	Intervention end	Follow-up period	Follow-up period
Time points		Week 0		Week 4		Month 3	Month 6
Screening/enrollment	Eligibility screening	•	•	—	—	—	—
	Informed consent	•	—	—	—	—	—
	Baseline measurement	•	—	—	—	—	—
	Random allocation	—	•	—	—	—	—
Intervention	Baduanjin exercise	—	•				•
	Free activities	—	•				•
Outcome assessment	Total effective rate	—	•	•	•	•	•
	Duration	—	•	•	•	•	•
	Attack frequency	—	•	•	•	•	•
	Dosage	—	•	•	•	•	•
	Stopping rate of nitroglycerin	—	•	•	•	•	•
	SAQ	—	•	•	•	•	•
	SF-36	—	•	•	•	•	•
	ECG	—	•	—	•	—	—
	Serum lipids	—	•	—	•	—	—
	Hs-CRP	—	•	—	•	—	—
	The TCM syndrome scores	—	•	•	•	•	•
	Composition of gut microbiota	—	•	—	•	—	—
	TMAO	—	•	—	•	—	—
Safety index	—	—	•	—	•	—	—
Adverse events	—	—	•				•